Open AccessReply to Yan and Muller, “Remdesivir for COVID-19: Why Not Dose Higher?”
Author(s) -
Kavita Juneja,
Rita Humeniuk,
Danielle Porter,
Huyen Cao,
Joy Y. Feng
Publication year - 2021
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00085-21
Subject(s) - covid-19 , dosing , medicine , betacoronavirus , coronavirus , pandemic , pharmacology , virology , intensive care medicine , disease , infectious disease (medical specialty) , outbreak